In recent years, drug discovery has become a search for targets that take the form of gene-expression differences between normal and disease states. One of the leading approaches has been based on ...
Experimental mRNA cancer vaccine shows potential for advanced stage cancer patients in Phase 1 trial
Interim data from the Phase I dose escalation part of the mRNA cancer immunotherapy (mRNA-4359), show promise in patients with advanced solid cancers. The investigational mRNA cancer immunotherapy is ...
Two pioneering scientists who created the technology behind life-saving Covid-19 vaccines have won the Nobel Prize in medicine or physiology. Dr. Katalin Karikó and Dr. Drew Weissman, both of the ...
NEW HAVEN, Conn. (Ivanhoe Newswire) – Scientists who developed the COVID-19 vaccine used a new technology called mRNA, or messenger RNA. Now, researchers at Yale University are building on that ...
WASHINGTON (AP) — So-called mRNA vaccines saved millions of lives during the COVID-19 pandemic — and now scientists are using that Nobel Prize-winning technology to try to develop vaccines and ...
June 29 (Reuters) - Sanofi (SASY.PA), opens new tab said that trials show the currently available mRNA technology behind the most successful COVID-19 shots will not be effective against influenza and ...
The mRNA COVID-19 vaccines might make some cancer treatments more effective. Lung cancer patients who received the vaccine within a few months of immunotherapy, which revs up the immune system, lived ...
Pfizer has released the full data from its phase 3 trial of an mRNA flu vaccine candidate, with the potential new shot demonstrating 34.5% greater efficacy compared to a control vaccine. Of 9,225 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback